Medical Properties Net Worth
Medical Properties Net Worth Breakdown | MPW |
Medical Properties Net Worth Analysis
Medical Properties' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Medical Properties' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Medical Properties' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Medical Properties' net worth analysis. One common approach is to calculate Medical Properties' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Medical Properties' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Medical Properties' net worth. This approach calculates the present value of Medical Properties' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Medical Properties' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Medical Properties' net worth. This involves comparing Medical Properties' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Medical Properties' net worth relative to its peers.
Enterprise Value |
|
To determine if Medical Properties is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Medical Properties' net worth research are outlined below:
Medical Properties appears to be risky and price may revert if volatility continues | |
The company reported the last year's revenue of 995.55 M. Reported Net Loss for the year was (556.09 M) with profit before taxes, overhead, and interest of 968.29 M. | |
Medical Properties has a poor financial position based on the latest SEC disclosures | |
About 63.0% of the company shares are owned by institutional investors | |
Latest headline from gurufocus.com: MPW Stock Rises Key Factors Driving Todays Movement |
Medical Properties uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Medical Properties Trust. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Medical Properties' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024 Upcoming Quarterly Report | View | |
25th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
22nd of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Medical Properties Target Price Consensus
Medical target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Medical Properties' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
12 | Hold |
Most Medical analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Medical stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Medical Properties Trust, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationMedical Properties Target Price Projection
Medical Properties' current and average target prices are 5.90 and 4.56, respectively. The current price of Medical Properties is the price at which Medical Properties Trust is currently trading. On the other hand, Medical Properties' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Medical Properties Market Quote on 1st of March 2025
Target Price
Analyst Consensus On Medical Properties Target Price
Know Medical Properties' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Medical Properties is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medical Properties Trust backward and forwards among themselves. Medical Properties' institutional investor refers to the entity that pools money to purchase Medical Properties' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Allianz Asset Management Ag | 2024-12-31 | 5 M | Wilsey Asset Management | 2024-12-31 | 4.7 M | Legal & General Group Plc | 2024-12-31 | 4.2 M | Group One Trading, Lp | 2024-09-30 | 3.9 M | Ubs Asset Mgmt Americas Inc | 2024-12-31 | 3.7 M | Jpmorgan Chase & Co | 2024-09-30 | 3.4 M | Principal Financial Group Inc | 2024-12-31 | 2.9 M | Amvescap Plc. | 2024-12-31 | 2.2 M | Jane Street Group Llc | 2024-12-31 | 2 M | Blackrock Inc | 2024-12-31 | 90.9 M | Vanguard Group Inc | 2024-12-31 | 84 M |
Follow Medical Properties' market capitalization trends
The company currently falls under 'Mid-Cap' category with a total capitalization of 3.54 B.Market Cap |
|
Project Medical Properties' profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.03) | (0.03) | |
Return On Capital Employed | 0.01 | 0.01 | |
Return On Assets | (0.04) | (0.03) | |
Return On Equity | (0.07) | (0.06) |
When accessing Medical Properties' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Medical Properties' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Medical Properties' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Medical Properties' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medical Properties Trust. Check Medical Properties' Beneish M Score to see the likelihood of Medical Properties' management manipulating its earnings.
Evaluate Medical Properties' management efficiency
Medical Properties Trust has Return on Asset of 0.0148 % which means that on every $100 spent on assets, it made $0.0148 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3863) %, meaning that it generated no profit with money invested by stockholders. Medical Properties' management efficiency ratios could be used to measure how well Medical Properties manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to -0.03 in 2025. Return On Capital Employed is likely to drop to 0.01 in 2025. At this time, Medical Properties' Total Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 1.5 B in 2025, whereas Other Current Assets are likely to drop slightly above 378 M in 2025.Last Reported | Projected for Next Year | ||
Book Value Per Share | 11.48 | 8.86 | |
Tangible Book Value Per Share | 9.92 | 10.42 | |
Enterprise Value Over EBITDA | 21.68 | 21.16 | |
Price Book Value Ratio | 0.35 | 0.33 | |
Price Fair Value | 0.35 | 0.33 | |
Enterprise Value Multiple | 21.68 | 21.16 | |
Enterprise Value | 4 B | 4.2 B |
Effective leadership at Medical Properties drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Enterprise Value Revenue 19.3772 | Revenue | Quarterly Revenue Growth (0.22) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medical Properties insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medical Properties' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Medical Properties insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Medical Properties Corporate Filings
8K | 27th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
12th of February 2025 Other Reports | ViewVerify | |
F4 | 6th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13th of November 2024 Other Reports | ViewVerify |
Medical Properties Earnings per Share Projection vs Actual
Medical Properties Corporate Directors
Caterina Mozingo | Independent Director | Profile | |
Michael Stewart | Lead Independent Director | Profile | |
Daniel Sparks | Independent Director | Profile | |
Tim Berryman | Director of Investor Relations | Profile |
Additional Tools for Medical Stock Analysis
When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.